LXEO - Lexeo Therapeutics, Inc.
7.2
-0.240 -3.333%
Share volume: 1,431,602
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.44
-0.24
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-13-2024 | 03-24-2025 | 05-12-2025 | 11-05-2025 | |
| Assets | |||||||
| Total Assets | 213.205 M | 192.007 M | 173.865 M | 146.942 M | 125.690 M | 143.844 M | |
| Current Assets | 198.089 M | 177.149 M | 159.458 M | 126.121 M | 105.274 M | 127.793 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 86.504 M | 70.918 M | 81.768 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 195.060 M | 174.981 M | 157.020 M | 35.014 M | 28.913 M | 40.996 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 7.012 M | 7.035 M | 3.390 M | |
| Property Plant Equipment | 1.044 M | 1.205 M | 1.180 M | 1.028 M | 1.045 M | 1.230 M | |
| Other Assets | 14.072 M | 13.653 M | 13.227 M | 19.793 M | 19.371 M | 14.821 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 213.205 M | 192.007 M | 173.865 M | 146.942 M | 125.690 M | 143.844 M | |
| Total liabilities | 30.255 M | 27.059 M | 34.539 M | 30.100 M | 37.575 M | 23.013 M | |
| Total current liabilities | 21.630 M | 18.877 M | 26.818 M | 22.846 M | 30.823 M | 17.271 M | |
| Accounts Payable | 4.297 M | 5.765 M | 8.438 M | 6.417 M | 11.981 M | 4.656 M | |
| Other liabilities | 8.625 M | 8.182 M | 7.721 M | 7.254 M | 6.752 M | 5.742 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 8.625 M | 8.182 M | 7.721 M | 7.254 M | 6.752 M | 5.742 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 182.950 M | 164.948 M | 139.326 M | 116.842 M | 88.115 M | 120.831 M | |
| Common stock | 386.472 M | 389.721 M | 393.588 M | 397.135 M | 401.015 M | 479.974 M | |
| Retained earnings | -203.522 M | -224.760 M | -254.249 M | -280.173 M | -312.829 M | -359.215 M |